Drug Shortage Report for KALETRA

Last updated on 2021-05-04 History
Report ID 138134
Drug Identification Number 02312301
Brand name KALETRA
Common or Proper name lopinavir/ritonavir tablets
Company Name ABBVIE CORPORATION
Market Status MARKETED
Active Ingredient(s) LOPINAVIR RITONAVIR
Strength(s) 100MG 25MG
Dosage form(s) TABLET
Route of administration ORAL ORAL
Packaging size 60 Tablets bottle
ATC code J05AR
ATC description DIRECT ACTING ANTIVIRALS
Reason for shortage Demand increase for the drug.
Anticipated start date 2021-06-04
Actual start date
Estimated end date 2021-07-05
Actual end date
Shortage status Anticipated shortage
Updated date 2021-05-04
Company comments As a result of an increase in demand for KALETRA® (lopinavir/ritonavir film-coated tablets, 100/25mg), we are closely monitoring our inventory of KALETRA film-coated tablets (100/25mg). KALETRA film-coated tablets (200/50 mg) and KALETRA oral solution (80/20 mg/mL) continue to be available. Should you have any questions, please contact our Customer Service Department at 1-888-704-8270.
Health Canada comments
Contact Address 8401 TRANS-CANADA HIGHWAY
SAINT-LAURENT, QUEBEC
CANADA H4S 1Z1
Company contact information Should you require any additional information, please contact our Customer Service Department at 1-888-704-8270.

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v16 2021-05-04 French Compare
v15 2021-05-04 English Compare
v14 2021-05-04 English Compare
v13 2021-05-04 English Compare
v12 2021-05-04 English Compare
v11 2021-05-03 English Compare
v10 2021-05-03 English Compare
v9 2021-05-03 English Compare
v8 2021-05-03 English Compare
v7 2021-04-27 English Compare
v6 2021-04-27 French Compare
v5 2021-04-27 English Compare
v4 2021-04-27 English Compare
v3 2021-04-27 French Compare
v2 2021-04-27 English Compare
v1 2021-04-27 English Compare